AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUSJ. Leonard, M. Trneny,K. Izutsu,N. Fowler, X. Hong,H. Zhang,F. Offner, A. Scheliga, G. Nowakowski,A. Pinto,F. Re, L. Fogliatto,P. Scheinberg,I. Flinn,C. Moreira, M. Czuczman, S. Kalambakas,P. Fustier,C. Wu,J. GribbenHematological Oncology（2019）引用 10|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
